Search research articles
Contact Us
Filters
Showing results (131-140 of 179) with videos related to
Page
of 18
Sort By:
Chemical Communications (Cambridge, England)
|
June 29, 2011
Unprecedented incorporation of α-emitter radioisotope 213Bi into porphyrin chelates with reference to a daughter isotope mediated assistance mechanism
Stéphane Le Gac, Btissam Najjari, Nicolas Motreff, et al.
Cancer Letters
|
June 18, 2005
Cytotoxicity of PAI2, C595 and Herceptin vectors labeled with the alpha-emitting radioisotope Bismuth-213 for ovarian cancer cell monolayers and clusters
Yan J Song, Chang F Qu, Syed M A Rizvi, et al.
Mutagenesis
|
May 21, 2019
DNA damage in human whole blood caused by radiopharmaceuticals evaluated by the comet assay
Heinz H Schmeiser, Karl-Rudolf Muehlbauer, Walter Mier, et al.
Frontiers in Medicine
|
November 20, 2015
Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model
Nolwenn Fichou, Sébastien Gouard, Catherine Maurel, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
June 11, 2020
Tris-{hydridotris(1-pyrazolyl)borato}actinide Complexes: Synthesis, Spectroscopy, Crystal Structure, Bonding Properties and Magnetic Behaviour
Christos Apostolidis, Attila Kovács, Olaf Walter, et al.
Molecular Cancer Therapeutics
|
September 21, 2022
Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the Treatment of HER2pos Cancer
Magdalena Rodak, Yana Dekempeneer, Maria Wojewódzka, et al.
Nuclear Medicine Communications
|
December 4, 2004
Importance of receptor density in alpha radioimmunotherapy in B cell malignancies: an in-vitro study
Katia Vandenbulcke, Hubert Thierens, Fritz Offner, et al.
Cancer Research
|
May 17, 2008
213Bi (alpha-emitter)-antibody targeting of breast cancer metastases in the neu-N transgenic mouse model
Hong Song, Karineh Shahverdi, David L Huso, et al.
EJNMMI Radiopharmacy and Chemistry
|
March 23, 2018
Optimizing labelling conditions of <sup>213</sup>Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapy
Ho Sze Chan, Erik de Blois, Mark W Konijnenberg, et al.
Cancers
|
April 3, 2021
Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model
Marisa Capitao, Justine Perrin, Sylvain Simon, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 179) with videos related to
Sort By:
Page
of 18
Chemical Communications (Cambridge, England)
|
June 29, 2011
Unprecedented incorporation of α-emitter radioisotope 213Bi into porphyrin chelates with reference to a daughter isotope mediated assistance mechanism
Stéphane Le Gac, Btissam Najjari, Nicolas Motreff, et al.
Cancer Letters
|
June 18, 2005
Cytotoxicity of PAI2, C595 and Herceptin vectors labeled with the alpha-emitting radioisotope Bismuth-213 for ovarian cancer cell monolayers and clusters
Yan J Song, Chang F Qu, Syed M A Rizvi, et al.
Mutagenesis
|
May 21, 2019
DNA damage in human whole blood caused by radiopharmaceuticals evaluated by the comet assay
Heinz H Schmeiser, Karl-Rudolf Muehlbauer, Walter Mier, et al.
Frontiers in Medicine
|
November 20, 2015
Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model
Nolwenn Fichou, Sébastien Gouard, Catherine Maurel, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
June 11, 2020
Tris-{hydridotris(1-pyrazolyl)borato}actinide Complexes: Synthesis, Spectroscopy, Crystal Structure, Bonding Properties and Magnetic Behaviour
Christos Apostolidis, Attila Kovács, Olaf Walter, et al.
Molecular Cancer Therapeutics
|
September 21, 2022
Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the Treatment of HER2pos Cancer
Magdalena Rodak, Yana Dekempeneer, Maria Wojewódzka, et al.
Nuclear Medicine Communications
|
December 4, 2004
Importance of receptor density in alpha radioimmunotherapy in B cell malignancies: an in-vitro study
Katia Vandenbulcke, Hubert Thierens, Fritz Offner, et al.
Cancer Research
|
May 17, 2008
213Bi (alpha-emitter)-antibody targeting of breast cancer metastases in the neu-N transgenic mouse model
Hong Song, Karineh Shahverdi, David L Huso, et al.
EJNMMI Radiopharmacy and Chemistry
|
March 23, 2018
Optimizing labelling conditions of <sup>213</sup>Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapy
Ho Sze Chan, Erik de Blois, Mark W Konijnenberg, et al.
Cancers
|
April 3, 2021
Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model
Marisa Capitao, Justine Perrin, Sylvain Simon, et al.
Page
of 18